Market Place
Sourcing Support
All News #Library
Others
SOTIO to Present Preclinical Data on ADCs at 2025 AACR Meeting
26 Mar 2025 //
BUSINESSWIRE
SOTIO Unveils Preclinical Data on SOT109 for Colorectal Cancer
03 Mar 2025 //
BUSINESSWIRE
SOTIO: First Patient Dosed In SOT201 Phase 1 Solid Tumor Study
28 May 2024 //
BUSINESSWIRE
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
23 May 2024 //
BUSINESSWIRE
SOTIO Presents Data on SOT201 Immunocytokine at SITC Annual Meeting
31 Oct 2023 //
BUSINESSWIRE
Sotio terminates three trials studying its IL-15 superagonist
13 Oct 2023 //
ENDPTS
SOTIO Announces First Patients Dosed in Two Combination Arms of CLAUDIO-01 Study
11 Oct 2023 //
BUSINESSWIRE
SOTIO Presents Preclinical Data from BOXR CAR-T & Trial of Ph 2 AURELIO-04
10 Nov 2022 //
GLOBENEWSWIRE
SOTIO to Present the AURELIO-04 Phase 2 Study Design
18 Oct 2022 //
GLOBENEWSWIRE
SOTIO Doses First Patient in AURELIO-04 PII Trial of SOT101 + KEYTRUDA
26 Jul 2022 //
GLOBENEWSWIRE
Data from SOTIO`s Phase 1/1b AURELIO-03 Trial of SOT101 in Solid Tumors
26 May 2022 //
GLOBENEWSWIRE
SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102
26 Apr 2022 //
GLOBENEWSWIRE
SOTIO says Oral and Multiple Poster Presentations on Key Programs at AACR
16 Mar 2022 //
GLOBENEWSWIRE
Fresh from $316M raise, Sotio inks Merck deal for Keytruda combo trial
09 Dec 2021 //
FIERCEBIOTECH
A quiet Czech biotech bags $315M to drive its cancer pipeline
02 Dec 2021 //
ENDPTS
SOTIO Strengthens its Strategic Advisory Board with Esteemed Oncology Experts
18 Nov 2021 //
GLOBENEWSWIRE
SOTIO expands its ADC pipeline via agreement with LegoChem
17 Nov 2021 //
THEPHARMALETTER
SOTIO, LegoChem Biosciences Enter ADC License Agreement
16 Nov 2021 //
CONTRACTPHARMA
SOTIO Expands its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration
16 Nov 2021 //
GLOBENEWSWIRE
SOTIO to Present New Data from Phase 1 Study of SOT101
03 Nov 2021 //
GLOBENEWSWIRE
SOTIO to Present Biomarker Data from its SOV01 – DCVAC/OvCa Phase 2 Study
11 May 2021 //
GLOBENEWSWIRE
SOTIO Demonstrates Strong Potential of SOT102 (ADC Targeting Claudin 18.2)
13 Apr 2021 //
GLOBNEWSWIRE
SOTIO to Present Preclinical Results Describing SOT102
06 Apr 2021 //
GLOBENEWSWIRE
SOTIO Presents Interim Data from its Ph1/1b Study of SO-C101
11 Nov 2020 //
GLOBENEWSWIRE
SOTIO to Present New Data on the IL-15 superagonist SO-C101
04 Nov 2020 //
GLOBENEWSWIRE
Sotio Acquires Rights to BOXR Cell Therapy Platform
31 Aug 2020 //
CONTRACTPHARMA
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
31 Aug 2020 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.